Beneficial renal effect of insulin glargine 300 U/ml initiation in type 2 diabetes mellitus patients previously treated with insulin

被引：0
|
作者：
Popovic, D. S. [1 ,2 ]
Lelik-Tubic, K. [3 ]
机构：
[1] Clin Ctr Vojvodina, Clin Endocrinol Diabet & Metab Disorders, Novi Sad, Serbia
[2] Univ Novi Sad, Med Fac, Novi Sad, Serbia
[3] Healthcare Ctr Alibunar, Alibunar, Serbia
来源：
DIABETES STOFFWECHSEL UND HERZ | 2020年 / 29卷 / 06期
关键词：
DISEASE;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：364 / +
页数：3
相关论文
共 50 条
  • [21] Insulin Glargine 300 U/mL Therapy in Children and Adolescents with Type 1 Diabetes
    Maffeis, Claudio
    Rabbone, Ivana
    PEDIATRIC DRUGS, 2022, 24 (05) : 499 - 512
  • [22] Insulin Glargine 300 U/mL Therapy in Children and Adolescents with Type 1 Diabetes
    Claudio Maffeis
    Ivana Rabbone
    Pediatric Drugs, 2022, 24 : 499 - 512
  • [23] Commentary to "Differential Effect of Hypoalbuminemia on Hypoglycemia on Type 2 Diabetes Patients Treated with Insulin Glargine 300 U/ml and Insulin Degludec" by Kawaguchi et al. Diabetes Therapy 2019
    Pieber, Thomas R.
    Bardtrum, Lars
    Isendahl, Joakim
    Wagner, Lily
    Nishimura, Rimei
    DIABETES THERAPY, 2020, 11 (02) : 561 - 567
  • [24] Commentary to “Differential Effect of Hypoalbuminemia on Hypoglycemia on Type 2 Diabetes Patients Treated with Insulin Glargine 300 U/ml and Insulin Degludec” by Kawaguchi et al. Diabetes Therapy 2019
    Thomas R. Pieber
    Lars Bardtrum
    Joakim Isendahl
    Lily Wagner
    Rimei Nishimura
    Diabetes Therapy, 2020, 11 : 561 - 567
  • [25] New insulin glargine 300 U/ml: glycaemic control and hypoglycaemia in insulin-naive people with type 2 diabetes mellitus (EDITION 3)
    Bolli, G. B.
    Riddle, M. C.
    Bergenstal, R. M.
    Ziemen, M.
    Sestakauskas, K.
    Goyeau, H.
    Home, P. D.
    DIABETOLOGIA, 2014, 57 : S387 - S388
  • [26] Safety and efficacy of insulin glargine 300 u/mL compared with other basal insulin therapies in patients with type 2 diabetes mellitus: a network meta-analysis
    Freemantle, Nick
    Chou, Engels
    Frois, Christian
    Zhuo, Daisy
    Lehmacher, Walter
    Vlajnic, Aleksandra
    Wang, Hongwei
    Chung, Hsing-wen
    Zhang, Quanwu
    Wu, Eric
    Gerrits, Charles
    BMJ OPEN, 2016, 6 (02):
  • [27] Improved real-world outcomes for type 2 diabetes patients on basal-bolus insulin therapy switching to insulin glargine 300 U/ml vs. insulin glargine 100 U/ml and insulin Detemir
    Wu, Jasmanda
    Bailey, Timothy S.
    Bosnyak, Zsolt
    Westerbacka, Jukka
    Gupta, Rishab A.
    Menon, Arjun A.
    Nicholls, Charlie
    Blonde, Lawrence
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 416 - 417
  • [28] THE EFFECT OF GLARGINE AND NPH INSULIN IN PATIENTS WITH DIABETES MELLITUS TYPE 2
    Nechevska, L.
    Nechevski, M.
    Nechevska, E.
    Boskovski, B.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [29] Improved Glycemic Control with Insulin Glargine 300 U/mL vs. Glargine 100 U/mL in Type 1 Diabetes
    Paola, Lucidi
    Cioli, Patrizia
    Candeloro, Paola
    Andreoli, Anna Marinelli
    Bolli, Geremia B.
    Fanelli, Carmine G.
    Porcellati, Francesca
    DIABETES, 2020, 69
  • [30] Effectiveness and Safety of Initiation and Titration of Insulin Glargine 300 U/mL in Insulin-Naive Patients with Type 2 Diabetes Mellitus Uncontrolled on Oral Antidiabetic Drug Treatment in Turkey: The EASE Study
    Cetinarslan, Berrin
    Cetinkalp, Sevki
    Kaya, Ahmet
    Ersoy, Canan
    Kebapci, Nur
    Comlekci, Abdurrahman
    Tutuncu, Neslihan Bascil
    Deyneli, Oguzhan
    Oguz, Aytekin
    Ilkova, Hasan
    Yilmaz, Temel
    Hekimsoy, Zeliha
    Unubol, Mustafa
    Balci, Mustafa Kemal
    Atmaca, Ayseguel
    Dagdelen, Selcuk
    Yetkin, Ilhan
    Guler, Serdar
    Otunc, Goektuerk
    Ozhan, Leyla
    ENDOCRINOLOGY RESEARCH AND PRACTICE, 2024, 28 (01): : 4 - 11
12345